NGM Biopharmaceuticals Inc buy me8
Start price
17.10.22
/
0%
€3.30
Target price
17.10.23
-
Performance (%)
68.18%
End price
29.10.22
€5.55
Summary
This prediction ended on 29.10.22 with a price of €5.55. With a performance of 68.18% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
NGM Biopharmaceuticals Inc | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% |
According to me8 what are the pros and cons of NGM Biopharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Little innovation
Comments by me8 for this prediction
In the thread NGM Biopharmaceuticals Inc diskutieren
Buy NGM Biopharmaceuticals Inc
In the thread Trading NGM Biopharmaceuticals Inc
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.